Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism
2009
Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15
2014
Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties
2014
STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer
2012
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection
2007
Sequence, Organization, Chromosomal Localization, and Alternative Splicing of the Human Serine Protease Inhibitor Gene Hurpin ( PI13 ) Which Is Upregulated in Psoriasis
2001
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Regulation of growth differentiation factor 15 expression by intracellular iron
2008 StandoutNobel
The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10
2012
Microenvironmental regulation of tumour angiogenesis
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Heparin-Protein Interactions
2002 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate
2011
MEK1/2 inhibitors in the treatment of gynecologic malignancies
2014
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Thyroid cancer
2016 Standout
Inflammatory links between obesity and metabolic disease
2011 Standout
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
2007
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression
2000
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Expression of CXCL14 and its anticancer role in breast cancer
2012
Atopic dermatitis
2015 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Compartmentalized AMPK Signaling Illuminated by Genetically Encoded Molecular Sensors and Actuators
2015
Head and neck cancer
2008 Standout
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
2014
The biology and function of fibroblasts in cancer
2016 Standout
Modulation of CXCL14 (BRAK) expression in prostate cancer
2005
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
2007
Cancer-associated fibroblasts and tumor growth – bystanders turning into key players
2009
Hallmarks of cancer: Interactions with the tumor stroma
2010
Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling
2013
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy
2018
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
2007
Peeling off the genetics of atopic dermatitis–like congenital disorders
2014
Identification and validation of genes involved in cervical tumourigenesis
2011
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
2001
Apoptosis-based therapies
2002
Desmosome structure, composition and function
2007
Remodelling the extracellular matrix in development and disease
2014 Standout
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis
2010
Host-Microbe Interactions: Shaping the Evolution of the Plant Immune Response
2006 Standout
CXCL14 expression and potential function in pancreatic cancer
2007
Emerging Biological Principles of Metastasis
2017 Standout
Fibroblasts as architects of cancer pathogenesis
2012
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures
2008
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
2009
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
TGFβ in Cancer
2008 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good
2011
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo
2009
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
2017
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Prospects for MEK inhibitors for treating cancer
2014
Clinical management of Staphylococcus aureus bacteraemia
2011
Neutrophils in cancer: neutral no more
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Association between gene expression profile and tumor invasion in oral squamous cell carcinoma
2004
Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity
2004
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Comèl-Netherton syndrome defined as primary immunodeficiency
2009
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
2007
Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
2014
Molecular characterization of the tumor microenvironment in breast cancer
2004
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF -Mutant Thyroid Cancer
2014
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
2010
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
2010
Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo
2005
Serpin Structure, Mechanism, and Function
2002 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
2011
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
A Second Kazal-Like Protease Inhibitor from Phytophthora infestans Inhibits and Interacts with the Apoplastic Pathogenesis-Related Protease P69B of Tomato
2005
CXC chemokines in angiogenesis
2000
Platelet‐Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma
2017
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Predicting cancer development in oral leukoplakia: ten years of translational research.
2000
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
2003
Molecular Genetics of Head and Neck Cancer
2002
Fibroblast heterogeneity in the cancer wound
2014
LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent Interaction
2007
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome
2013
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
2017
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
2016
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
2017
Activation of fibroblasts in cancer stroma
2010
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Physiology of Microglia
2011 Standout
Works of Mitchell J. Frederick being referenced
BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells
2004
LBP-1b, LBP-9, and LBP-32/MGR Detected in Syncytiotrophoblasts from First-Trimester Human Placental Tissue and Their Transcriptional Regulation
2007
Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
2015
Cytokine-Induced Cytotoxic Function Expressed by Lymphocytes of the Innate Immune System: Distinguishing Characteristics of NK and LAK Based on Functional and Molecular Markers
1997
Identification and cDNA Cloning of headpin, a Novel Differentially Expressed Serpin That Maps to Chromosome 18q
1999
In Vivo Expression of the Novel CXC Chemokine BRAK in Normal and Cancerous Human Tissue
2000
Human LBP-32/MGR is a Repressor of the P450scc in Human Choriocarcinoma Cell Line JEG-3
2006
Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections
2005
Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells
2000
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
1998
Expression of LEKTI domains 6–9′ in the baculovirus expression system: recombinant LEKTI domains 6–9′ inhibit trypsin and subtilisin A
2004
Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cells
1996
Identification of 9 Genes Differentially Expressed in Head and Neck Squamous Cell Carcinoma
2003
Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution
2004
Chemokines in cancer
2001
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells
2011
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
2009
Inhibition of Serine Proteinases Plasmin, Trypsin, Subtilisin A, Cathepsin G, and Elastase by LEKTI: A Kinetic Analysis
2003
MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivo
2010
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
1998